JTZ-951

DRUG4 trials

Sponsors

Akros Pharma Inc., JW Pharmaceutical

Conditions

Anemia in Chronic Kidney DiseaseAnemia of Chronic Kidney Disease

Phase 1

Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease

CompletedNCT01971164

Akros Pharma Inc.Anemia of Chronic Kidney Disease

Start: 2013-05-31End: 2014-07-31Updated: 2014-07-14

Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease

CompletedNCT01978587

Akros Pharma Inc.Anemia in Chronic Kidney Disease

Start: 2013-10-31End: 2014-01-31Updated: 2014-03-18

Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease

CompletedNCT02581124

Akros Pharma Inc.Anemia of Chronic Kidney Disease

Start: 2015-10-31End: 2016-04-30Updated: 2016-04-28

Phase 3

A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.

CompletedNCT04027517

JW PharmaceuticalAnemia of Chronic Kidney Disease

Start: 2019-01-15End: 2021-02-23Updated: 2021-03-22